Financial payments by orthopedic device makers to orthopedic surgeons

Archives of Internal Medicine

Volumn 171, Issue 19, 2011, Pages 1759-1765

  Hockenberry, Jason M ^a,b,e   Weigel, Paula ^a   Auerbach, Andrew ^d   Cram, Peter ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b Iowa City Veterans Affairs Medical System ^*  (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; HEALTH CARE INDUSTRY; IMPLANT; LAW SUIT; MEDICAL FEE; MONEY; ORTHOPEDIC EQUIPMENT; PRIORITY JOURNAL; SURGEON; UNIVERSITY HOSPITAL;

ARTHROPLASTY, REPLACEMENT; CODES OF ETHICS; CONFLICT OF INTEREST; FACULTY, MEDICAL; HUMANS; INDUSTRY; ORTHOPEDIC EQUIPMENT; ORTHOPEDIC PROCEDURES; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIANS; PROSTHESES AND IMPLANTS; REFERRAL AND CONSULTATION; SOCIETIES, MEDICAL; TRUTH DISCLOSURE; UNITED STATES;

EID: 80054881029     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.454     Document Type: Article

References (35)

1. Chren MM, Landefeld CS, Murray TH. Doctors, drug companies, and gifts. JAMA. 1989;262(24):3448-3451. (Pubitemid 20016706)
2. Lim EV, Aquino NJ. The orthopaedic surgeon and manufacturing industry relationship: ethical guidelines. Clin Orthop Relat Res. 1999;(368):279-286. (Pubitemid 29534005)
3. Coyle SL; Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Physician-industry relations, part 1: individual physicians. Ann Intern Med. 2002;136(5):396-402.
4. Crowninshield RD, Callaghan JJ. The orthopaedic profession and the industry partnership. Clin Orthop Relat Res. 2007;457:73-77. (Pubitemid 46573398)
5. White AP, Vaccaro AR, Zdeblick T. Counterpoint: physician-industry relationships can be ethically established, and conflicts of interest can be ethically managed. Spine (Phila Pa 1976). 2007;32(11)(suppl):S53-S57.
6. Steinbrook R. Online disclosure of physician-industry relationships. N Engl JMed. 2009;360(4):325-327.
7. Steinbrook R. Disclosure of industry payments to physicians. N Engl JMed. 2008; 359(6):559-561.
8. Campbell EG, Moy B, Feibelmann S, Weissman JS, Blumenthal D. Institutional academic industry relationship: results of interviews with university leaders. Account Res. 2004;11(2):103-118.
9. Blumenthal D, Causino N, Campbell E, Louis KS. Relationships between academic institutions and industry in the life sciences-an industry survey. N Engl J Med. 1996;334(6):368-373. (Pubitemid 26049591)
10. Zinner DE, Bjankovic D, Clarridge B, Blumenthal D, Campbell EG. Participation of academic scientists in relationships with industry. Health Aff (Millwood). 2009; 28(6):1814-1825.
11. Campbell EG, Weissman JS, Vogeli C, et al. Financial relationships between institutional review board members and industry. N Engl J Med. 2006;355(22): 2321-2329. (Pubitemid 44837780)
12. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008;299(15):1800-1812. (Pubitemid 351549971)
13. Abelson R. Medtronic, again questioned over payments to doctors, is subject of senator's inquiry. New York Times. September 27, 2007:C3.
14. Armstrong D, Burton TM. UCLA surgeon didn't report payments. Wall Street Journal. May 28, 2009:A4.
15. Harris G, Carey B, Roberts J. Psychiatrists, children, and drug industry's role. New York Times. May 10, 2007. http://www.nytimes.com/2007/05/ 10/health/ 10psyche.html. Accessed May 2011.
16. Marra R Jr. Monitoring and deferred prosecution agreements terminated with companies in hip and knee replacement industry. Newark NJ: US Dept of Justice; March 30, 2009. http://www.fbi.gov/newark/press-releases/2009/nk033009a .htm. Accessed May 2011.
17. Zimmer 2008 10-K filing with theSEC. Retrieved May7, 2010. http://files.shareholder .com/downloads/ZMH/1342925391x0x281451/E1F69B3A-9CBC- 4C2E-B807-58B70AACCC5F/zimmer-2008AR.pdf. Accessed May 2011.
18. 15th Annual physician compensation survey. Mod Healthc. July 14, 2008:28.
19. Okike K, Kocher MS, Wei EX, Mehlman CT, Bhandari M. Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med. 2009;361(15):1466-1474.
20. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-380. (Pubitemid 30051756)
21. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ. 1993;149(10):1401-1407. (Pubitemid 24036918)
22. Goldstein J. Device makers post payments to docs online. Wall Street Journal Health Blog Web site. http://blogs.wsj.com/health/2007/10/31/device- makers-post-payments-to-docs-online/. Published October 31, 2007. Accessed June 2009.
23. Jureidini JN, McHenry LB. Key opinion leaders and paediatric antidepressant overprescribing. Psychother Psychosom. 2009;78(4):197-201.
24. Meffert JJ. Key opinion leaders: where they come from and how that affects the drugs you prescribe. Dermatol Ther. 2009;22(3):262-268.
25. Moynihan R. Key opinion leaders: independent experts or drug representatives in disguise? BMJ. 2008;336(7658):1402-1403. (Pubitemid 351946976)
26. Buckwell C. Should the drug industry work with key opinion leaders? yes. BMJ. 2008;336(7658):1404. doi:10.1136/bmj.39541.702870.59.
27. Fava GA. Should the drug industry work with key opinion leaders? no. BMJ. 2008; 336(7658):1405. doi:10.1136/bmj.39541.731493.59.
28. Fallat ME, Glover J; American Academy of Pediatrics, Committee on Bioethics. Professionalism in pediatrics. Pediatrics. 2007;120(4):e1123-e1133. doi:10.1542 /peds.2007-2230.
29. Keim SM, Mays MZ, Grant D. Interactions between emergency medicine programs and the pharmaceutical industry. Acad Emerg Med. 2004;11(1):19-26. (Pubitemid 38055782)
30. Sierles FS, Brodkey AC, Cleary LM, et al. Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294 (9):1034-1042. (Pubitemid 41248444)
31. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ. 1995;153(5):553- 559.
32. Gelberman RH, Samson D, Mirza SK, Callaghan JJ, Pellegrini VD Jr. Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust. J Bone Joint Surg Am. 2010;92(3):765-777.
33. AAOS opinions on ethics and professionalism. American Academy of Orthopaedic Surgeons Web site. http://www.aaos.org/about/papers/ethics/1204eth. asp. Published February 1992. Updated September 2005. Accessed May 2011.
34. Patient Protection and Affordable Care Act, Pub L No. 111-148, 124 Stat 119, 42 USC §18001 Note (2010).
35. Campbell EG, Zinner DE. Disclosing industry relationships-toward an improved federal research policy. N Engl J Med. 2010;363(7):604-606.